BACKGROUND: Recent data have shown that plasma levels of lipopolysaccharide (LPS) are a quantitative indicator of microbial translocation in HIV infected individuals. OBJECTIVES: To assess the impact of residual viral replication on plasma LPS in HAART-treated HIV+ subjects with <50copies/ml HIV-1 RNA and to evaluate LPS changes during repeated HAART interruptions not exceeding 2-month duration. STUDY DESIGN: LPS was measured in 44 HIV+ subjects at T0 (during HAART) and at day 15 of the first and fourth HAART interruption. Ten uninfected, healthy donors were studied as well. Residual plasma HIV-1 RNA was measured at T0 by an ultra-ultrasensitive method with limit of detection of 2.5copies HIV-1 RNA/ml. Subjects with less than 2.5copies/ml (fully suppressed - FS) were compared to those with 2.5-50copies/ml (partially suppressed - PS). RESULTS: At T0, plasma LPS levels were comparable in FS and uninfected subjects, whereas in PS they were higher than in uninfected subjects (p=0.049). After 4 HAART interruptions, they did not change significantly. However, LPS values were lower in FS than in PS (p=0.020). An inverse correlation was found between CD4 and LPS levels (p=0.044) in PS group only. CONCLUSIONS: A reduced degree of microbial translocation was seen in subjects with a more complete suppression of viral replication. Repeated HAART interruptions had no significant impact on plasma LPS levels.
BACKGROUND: Recent data have shown that plasma levels of lipopolysaccharide (LPS) are a quantitative indicator of microbial translocation in HIV infected individuals. OBJECTIVES: To assess the impact of residual viral replication on plasma LPS in HAART-treated HIV+ subjects with <50copies/ml HIV-1 RNA and to evaluate LPS changes during repeated HAART interruptions not exceeding 2-month duration. STUDY DESIGN: LPS was measured in 44 HIV+ subjects at T0 (during HAART) and at day 15 of the first and fourth HAART interruption. Ten uninfected, healthy donors were studied as well. Residual plasma HIV-1 RNA was measured at T0 by an ultra-ultrasensitive method with limit of detection of 2.5copies HIV-1 RNA/ml. Subjects with less than 2.5copies/ml (fully suppressed - FS) were compared to those with 2.5-50copies/ml (partially suppressed - PS). RESULTS: At T0, plasma LPS levels were comparable in FS and uninfected subjects, whereas in PS they were higher than in uninfected subjects (p=0.049). After 4 HAART interruptions, they did not change significantly. However, LPS values were lower in FS than in PS (p=0.020). An inverse correlation was found between CD4 and LPS levels (p=0.044) in PS group only. CONCLUSIONS: A reduced degree of microbial translocation was seen in subjects with a more complete suppression of viral replication. Repeated HAART interruptions had no significant impact on plasma LPS levels.
Authors: Jessica L Reynolds; Supriya D Mahajan; Ravikumar Aalinkeel; Bindukumar Nair; Donald E Sykes; Stanley A Schwartz Journal: Immunol Invest Date: 2011-03-22 Impact factor: 3.657
Authors: Natalie L Wilson; David E Vance; Linda D Moneyham; James L Raper; Michael J Mugavero; Sonya L Heath; Mirjam-Colette Kempf Journal: J Assoc Nurses AIDS Care Date: 2014-07-22 Impact factor: 1.354
Authors: Silvia Baroncelli; Maria Franca Pirillo; Clementina Maria Galluzzo; Anna Degli Antoni; Nicoletta Ladisa; Daniela Francisci; Gabriella d'Ettorre; Daniela Segala; Angela Vivarelli; Federica Sozio; Oscar Cirioni; Liliana Elena Weimer; Vincenzo Fragola; Giustino Parruti; Marco Floridia Journal: AIDS Res Hum Retroviruses Date: 2015-01 Impact factor: 2.205
Authors: N R Klatt; L D Harris; C L Vinton; H Sung; J A Briant; B Tabb; D Morcock; J W McGinty; J D Lifson; B A Lafont; M A Martin; A D Levine; J D Estes; J M Brenchley Journal: Mucosal Immunol Date: 2010-03-31 Impact factor: 7.313
Authors: Claire Deleage; Alexandra Schuetz; W Gregory Alvord; Leslie Johnston; Xing-Pei Hao; David R Morcock; Rungsun Rerknimitr; James L K Fletcher; Suwanna Puttamaswin; Nittaya Phanuphak; Robin Dewar; Joseph M McCune; Irini Sereti; Merlin Robb; Jerome H Kim; Timothy W Schacker; Peter Hunt; Jeffrey D Lifson; Jintanat Ananworanich; Jacob D Estes Journal: JCI Insight Date: 2016-07-07